The influence of the angiotensin I converting enzyme genotype in familial hypertrophic cardiomyopathy varies with the disease gene mutation

被引:85
作者
Tesson, F
Dufour, C
Moolman, JC
Carrier, L
AlMahdawi, S
Chojnowska, L
Dubourg, O
Soubrier, F
Brink, P
Komajda, M
Guicheney, P
Schwartz, K
Feingold, J
机构
[1] UNIV STELLENBOSCH, SCH MED, DEPT BIOCHEM MED, ZA-7505 TYGERBERG, SOUTH AFRICA
[2] ST MARYS HOSP, SCH MED, DEPT BIOCHEM & MOL GENET, LONDON W2 1PG, ENGLAND
[3] INST CARDIOL, WARSAW, POLAND
[4] GRP HOSP PITIE SALPETRIERE, GRP MYCOCARDIOPATHIES SOC FRANCAISE CARDIOL, F-75634 PARIS, FRANCE
[5] GRP HOSP ST LOUIS, PARIS, FRANCE
[6] UNIV STELLENBOSCH, SCH MED, DEPT INTERNAL MED, ZA-7505 TYGERBERG, SOUTH AFRICA
[7] UNIV PARIS 06, INSERM, U155, PARIS, FRANCE
[8] UNIV PARIS 07, INSERM, U155, PARIS, FRANCE
[9] GRP HOSP PITIE SALPETRIERE, IFR PHYSIOPATHOL & GENET CARDIOVASC, F-75634 PARIS, FRANCE
关键词
hypertrophic cardiomyopathy; sarcomeric protein; myosin heavy chain; myosin binding protein C; angiotensin-I converting enzyme; mutation; polymorphism;
D O I
10.1006/jmcc.1996.0332
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Familial hypertrophic cardiomyopathy is an autosomal dominant genetically heterogeneous disease characterized by a partial penetrance and variable expressivity. Previous studies showed that the extent of hypertrophy is influenced by the angiotensin I converting enzyme insertion/deletion (I/D) polymorphism. Recently, molecular genetic analysis revealed the existence of healthy carriers and that as many as a quarter of genetically affected individuals do not express the disease. This data prompted us to re-investigate the role of the angiotensin I converting enzyme polymorphism on hypertrophy by assessing both clinically affected individuals and healthy carriers. For this, several families with mutations in the cardiac myosin binding protein C or the beta-myosin heavy chain genes were analysed. The mean maximal intraventricular septum thickness was compared as a function of angiotensin I converting enzyme genotypes in all genetically affected individuals (n=114), and in subsets of subjects carrying either a splice acceptor site mutation in the cardiac myosin binding protein C gene (n=33), or various missense mutations in the cardiac beta-myosin heavy chain gene (n=81) or finally, mutations in the Arg403 codon of the beta-myosin heavy chain gene (n=54). Significant association between the D allele and hypertrophy was observed only in the case of Arg403 codon mutations (mean septum thickness for subjects with the DD genotype: 19.3 +/- 2.7 mm; with the ID genotype: 13.4 +/- 1.3 mm and with the II. genotype: 11.0 +/- 0.9 mm; P<0.02). These results were confirmed by the chi(2) test showing an over-representation of DD genotype in patients carrying an Arg403 codon mutation associated with septal hypertrophy (P<0.05). Our data confirms that the angiotensin I converting enzyme genotypes can influence the phenotypic expression of hypertrophy and shows that this influence depends on the mutation, raising the concept of multiple genetic modifiers in familial hypertrophic cardiomyopathy. (C) 1997 Academic Press Limited.
引用
收藏
页码:831 / 838
页数:8
相关论文
共 36 条
[1]  
ALMAHDAWI S, 1994, BRIT HEART J, V72, P105
[2]   ANGIOTENSIN-II STIMULATION OF PROTEIN-SYNTHESIS AND CELL-GROWTH IN CHICK HEART-CELLS [J].
BAKER, KM ;
ACETO, JF .
AMERICAN JOURNAL OF PHYSIOLOGY, 1990, 259 (02) :H610-H618
[3]   CARDIAC MYOSIN BINDING PROTEIN-C GENE SPLICE ACCEPTOR SITE MUTATION IS ASSOCIATED WITH FAMILIAL HYPERTROPHIC CARDIOMYOPATHY [J].
BONNE, G ;
CARRIER, L ;
BERCOVICI, J ;
CRUAUD, C ;
RICHARD, P ;
HAINQUE, B ;
GAUTEL, M ;
LABEIT, S ;
JAMES, M ;
BECKMANN, J ;
WEISSENBACH, J ;
VOSBERG, HP ;
FISZMAN, M ;
KOMAJDA, M ;
SCHWARTZ, K .
NATURE GENETICS, 1995, 11 (04) :438-440
[4]  
CARRIER L, 1995, CIRCULATION, V92, P232
[5]   HETEROGENEOUS MORPHOLOGIC EXPRESSION OF GENETICALLY TRANSMITTED HYPERTROPHIC CARDIOMYOPATHY - TWO-DIMENSIONAL ECHOCARDIOGRAPHIC ANALYSIS [J].
CIRO, E ;
NICHOLS, PF ;
MARON, BJ .
CIRCULATION, 1983, 67 (06) :1227-1233
[6]   FAMILIAL HYPERTROPHIC CARDIOMYOPATHY - MICROSATELLITE HAPLOTYPING AND IDENTIFICATION OF A HOT-SPOT FOR MUTATIONS IN THE BETA-MYOSIN HEAVY-CHAIN GENE [J].
DAUSSE, E ;
KOMAJDA, M ;
FETLER, L ;
DUBOURG, O ;
DUFOUR, C ;
CARRIER, L ;
WISNEWSKY, C ;
BERCOVICI, J ;
HENGSTENBERG, C ;
ALMAHDAWI, S ;
ISNARD, R ;
HAGEGE, A ;
BOUHOUR, JB ;
DESNOS, M ;
BECKMANN, J ;
WEISSENBACH, J ;
SCHWARTZ, K ;
GUICHENEY, P .
JOURNAL OF CLINICAL INVESTIGATION, 1993, 92 (06) :2807-2813
[7]   IDENTIFICATION OF A MUTATION NEAR A FUNCTIONAL SITE OF THE BETA-CARDIAC MYOSIN HEAVY-CHAIN GENE IN A FAMILY WITH HYPERTROPHIC CARDIOMYOPATHY [J].
DUFOUR, C ;
DAUSSE, E ;
FETLER, L ;
DUBOURG, O ;
BOUHOUR, JB ;
VOSBERG, HP ;
GUICHENEY, P ;
KOMAJDA, M ;
SCHWARTZ, K .
JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY, 1994, 26 (09) :1241-1247
[8]   EVIDENCE OF GENETIC-HETEROGENEITY IN 5 KINDREDS WITH FAMILIAL HYPERTROPHIC CARDIOMYOPATHY [J].
EPSTEIN, ND ;
FANANAPAZIR, L ;
LIN, HJ ;
MULVIHILL, J ;
WHITE, R ;
LALOUEL, JM ;
LIFTON, RP ;
NIENHUIS, AW ;
LEPPERT, M .
CIRCULATION, 1992, 85 (02) :635-647
[9]   GENOTYPE-PHENOTYPE CORRELATIONS IN HYPERTROPHIC CARDIOMYOPATHY - INSIGHTS PROVIDED BY COMPARISONS OF KINDREDS WITH DISTINCT AND IDENTICAL BETA-MYOSIN HEAVY-CHAIN GENE-MUTATIONS [J].
FANANAPAZIR, L ;
EPSTEIN, ND .
CIRCULATION, 1994, 89 (01) :22-32
[10]   ACE GENE TYPING [J].
FOGARTY, DG ;
MAXWELL, AP ;
DOHERTY, CC ;
HUGHES, AE ;
NEVIN, NC .
LANCET, 1994, 343 (8901) :851-851